PPARG and pulmonary fibrosis: To further investigate whether lathyrol’s inhibition of pulmonary fibrosis correlates with its activation of PPARγ, mice were pretreated with the PPARγ antagonist GW9662 before the intraperitoneal administration of lathyrol.